BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

690 related articles for article (PubMed ID: 28483542)

  • 21. Recent advances in cytokines in cutaneous and systemic lupus erythematosus.
    Mikita N; Ikeda T; Ishiguro M; Furukawa F
    J Dermatol; 2011 Sep; 38(9):839-49. PubMed ID: 21767292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skin CD4
    Zhao Z; Zhu H; Li Q; Liao W; Chen K; Yang M; Long D; He Z; Zhao M; Wu H; Lu Q
    J Autoimmun; 2022 Apr; 128():102811. PubMed ID: 35278775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
    Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P
    Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden.
    Grönhagen CM; Fored CM; Granath F; Nyberg F
    Br J Dermatol; 2011 Jun; 164(6):1335-41. PubMed ID: 21574972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of patients with isolated cutaneous lupus erythematosus versus systemic lupus erythematosus with cutaneous lupus erythematosus as the sole clinical feature: A monocentric study of 149 patients.
    Masseran C; Perray L; Murat de Montai Q; Mathian A; Teboul A; Francès C; Arnaud L; Costedoat-Chalumeau N; Amoura Z; Courvoisier DS; Barbaud A; Chasset F
    J Am Acad Dermatol; 2024 Jun; 90(6):1210-1217. PubMed ID: 38301924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Update on the Pathogenesis of Cutaneous Lupus Erythematosus and Its Role in Clinical Practice.
    Patel J; Borucki R; Werth VP
    Curr Rheumatol Rep; 2020 Aug; 22(10):69. PubMed ID: 32845411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic symptoms in the progression of cutaneous to systemic lupus erythematosus.
    Wieczorek IT; Propert KJ; Okawa J; Werth VP
    JAMA Dermatol; 2014 Mar; 150(3):291-6. PubMed ID: 24477339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous lupus erythematosus: updates on pathogenesis and associations with systemic lupus.
    Stannard JN; Kahlenberg JM
    Curr Opin Rheumatol; 2016 Sep; 28(5):453-9. PubMed ID: 27270345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comprehensive review of immune-mediated dermatopathology in systemic lupus erythematosus.
    Li Q; Wu H; Liao W; Zhao M; Chan V; Li L; Zheng M; Chen G; Zhang J; Lau CS; Lu Q
    J Autoimmun; 2018 Sep; 93():1-15. PubMed ID: 30017673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-17 in cutaneous lupus erythematosus.
    Tanasescu C; Balanescu E; Balanescu P; Olteanu R; Badea C; Grancea C; Vagu C; Bleotu C; Ardeleanu C; Georgescu A
    Eur J Intern Med; 2010 Jun; 21(3):202-7. PubMed ID: 20493423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Classification of lupus erythematosus based upon Japanese patients.
    Tsuchida T
    Autoimmun Rev; 2009 May; 8(6):453-5. PubMed ID: 19162249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoimmune Skin Conditions: Cutaneous Lupus Erythematosus.
    Foulke G; Helm LA; Clebak KT; Helm M
    FP Essent; 2023 Mar; 526():25-36. PubMed ID: 36913660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression pattern of tissue-resident memory T cells in cutaneous lupus erythematosus.
    Gu HJ; Song S; Roh JY; Jung Y; Kim HJ
    Lupus; 2021 Aug; 30(9):1427-1437. PubMed ID: 34013817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score.
    Braunstein I; Klein R; Okawa J; Werth VP
    Br J Dermatol; 2012 May; 166(5):971-5. PubMed ID: 22242767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The composition of the lupus band test (LBT) on the sun-protected non-lesional (SPNL) skin in patients with cutaneous lupus erythematosus (CLE).
    Cardinali C; Caproni M; Fabbri P
    Lupus; 1999; 8(9):755-60. PubMed ID: 10602449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of Immune Cells as a Therapy for Cutaneous Lupus Erythematosus.
    Soto JA; Melo-González F; Riedel CA; Bueno SM; Kalergis AM
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lupus erythematosus tumidus is a separate subtype of cutaneous lupus erythematosus.
    Schmitt V; Meuth AM; Amler S; Kuehn E; Haust M; Messer G; Bekou V; Sauerland C; Metze D; Köpcke W; Bonsmann G; Kuhn A
    Br J Dermatol; 2010 Jan; 162(1):64-73. PubMed ID: 19712116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pathogenesis of cutaneous lupus erythematosus: The aberrant distribution and function of different cell types in skin lesions.
    Zhou X; Yan J; Lu Q; Zhou H; Fan L
    Scand J Immunol; 2021 Jan; 93(1):e12933. PubMed ID: 32654170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenesis of Skin Injury of Systemic Lupus Erythematosus.
    Deng GM
    Curr Rheumatol Rep; 2018 Feb; 20(2):5. PubMed ID: 29464447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical characteristics of pediatric cutaneous lupus erythematosus: experience from a tertiary referral center in Korea.
    Lee SK; Baek J; Roh JY; Kim HJ
    Lupus; 2019 Jun; 28(7):888-892. PubMed ID: 31112454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.